Page last updated: 2024-08-22

platinum and crizotinib

platinum has been researched along with crizotinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pan, Z; Shen, Q; Shen, Y; Sun, K; Wang, Y; Zhang, X; Zhang, Z; Zhao, J; Zheng, J; Zhou, J; Zhu, Y	1

Other Studies

1 other study(ies) available for platinum and crizotinib

Article	Year
Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment. BMC cancer, 2018, 01-03, Volume: 18, Issue:1 Topics: Adult; Aged; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Crizotinib; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Pemetrexed; Platinum; Prognosis; Pyrazoles; Pyridines; Receptor Protein-Tyrosine Kinases; Survival Rate; Young Adult	2018

Article

Year

Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment.

BMC cancer, 2018, 01-03, Volume: 18, Issue:1

Topics: Adult; Aged; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Crizotinib; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Pemetrexed; Platinum; Prognosis; Pyrazoles; Pyridines; Receptor Protein-Tyrosine Kinases; Survival Rate; Young Adult

2018